{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T02:20:25Z","timestamp":1791166825986,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T00:00:00Z","timestamp":1446508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s13277-015-4340-z","type":"journal-article","created":{"date-parts":[[2015,11,3]],"date-time":"2015-11-03T13:10:07Z","timestamp":1446556207000},"page":"4945-4953","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Circulating miR-148\/152 family as potential biomarkers in hepatocellular carcinoma"],"prefix":"10.1007","volume":"37","author":[{"given":"Feng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houqun","family":"Ying","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangshun","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shukui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,3]]},"reference":[{"issue":"1","key":"4340_CR1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11\u201330.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4340_CR2","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1002\/hep.27388","volume":"61","author":"B Njei","year":"2015","unstructured":"Njei B, Rotman Y, Ditah I, Lim JK. Emerging trends in hepatocellular carcinoma incidence and mortality. Hepatology. 2015;61(1):191\u20139.","journal-title":"Hepatology"},{"issue":"9","key":"4340_CR3","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.4254\/wjh.v7.i9.1157","volume":"7","author":"AS Bodzin","year":"2015","unstructured":"Bodzin AS, Busuttil RW. Hepatocellular carcinoma: advances in diagnosis, management, and long term outcome. World J Hepatol. 2015;7(9):1157\u201367.","journal-title":"World J Hepatol"},{"key":"4340_CR4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.addr.2014.10.029","volume":"81","author":"N Yang","year":"2015","unstructured":"Yang N, Ekanem NR, Sakyi CA, Ray SD. Hepatocellular carcinoma and microRNA: new perspectives on therapeutics and diagnostics. Adv Drug Deliv Rev. 2015;81:62\u201374.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"4340_CR5","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.4161\/15384047.2014.955442","volume":"15","author":"SL Romero-Cordoba","year":"2014","unstructured":"Romero-Cordoba SL, Salido-Guadarrama I, Rodriguez-Dorantes M, Hidalgo- Miranda A. miRNA biogenesis: biological impact in the development of cancer. Cancer Biol Ther. 2014;15(11):1444\u201355.","journal-title":"Cancer Biol Ther"},{"key":"4340_CR6","first-page":"125094","volume":"2015","author":"H Lan","year":"2015","unstructured":"Lan H, Lu H, Wang X, Jin H. MicroRNAs as potential biomarkers in cancer: opportunities and challenges. Biomed Res Int. 2015;2015:125094.","journal-title":"Biomed Res Int"},{"issue":"10","key":"4340_CR7","doi-asserted-by":"crossref","first-page":"e603","DOI":"10.1097\/MD.0000000000000603","volume":"94","author":"L Jiang","year":"2015","unstructured":"Jiang L, Cheng Q, Zhang BH, Zhang MZ. Circulating microRNAs as biomarkers in hepatocellular carcinoma screening: a validation set from China. Medicine (Baltimore). 2015;94(10):e603.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"4340_CR8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2217\/bmm.14.102","volume":"9","author":"S Khoury","year":"2015","unstructured":"Khoury S, Tran N. Circulating microRNAs: potential biomarkers for common malignancies. Biomark Med. 2015;9(2):131\u201351.","journal-title":"Biomark Med"},{"key":"4340_CR9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1476-4598-12-43","volume":"12","author":"Y Chen","year":"2013","unstructured":"Chen Y, Song YX, Wang ZN. The microRNA-148\/152 family: multi-faceted players. Mol Cancer. 2013;12:43.","journal-title":"Mol Cancer"},{"issue":"11","key":"4340_CR10","doi-asserted-by":"crossref","first-page":"11367","DOI":"10.1007\/s13277-014-2471-2","volume":"35","author":"R Zhai","year":"2014","unstructured":"Zhai R, Kan X, Wang B, Du H, Long Y, Wu H, et al. miR-152 suppresses gastric cancer cell proliferation and motility by targeting CD151. Tumour Biol. 2014;35(11):11367\u201373.","journal-title":"Tumour Biol"},{"key":"4340_CR11","doi-asserted-by":"crossref","unstructured":"Joshi P, Jeon YJ, Lagana A, Middleton J, Secchiero P, Garofalo M, et al. MicroRNA-148a reduces tumorigenesis and increases TRAIL-induced apoptosis in NSCLC. Proc Natl Acad Sci USA. 2015;112(28):8650\u20135.","DOI":"10.1073\/pnas.1500886112"},{"issue":"31","key":"4340_CR12","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1038\/onc.2013.369","volume":"33","author":"JP Zhang","year":"2014","unstructured":"Zhang JP, Zeng C, Xu L, Gong J, Fang JH, Zhuang SM. MicroRNA-148a suppresses the epithelial-mesenchymal transition and metastasis of hepatoma cells by targeting Met\/Snail signaling. Oncogene. 2014;33(31):4069\u201376.","journal-title":"Oncogene"},{"key":"4340_CR13","doi-asserted-by":"crossref","first-page":"8087","DOI":"10.1038\/srep08087","volume":"5","author":"JG Zhang","year":"2015","unstructured":"Zhang JG, Shi Y, Hong DF, Song M, Huang D, Wang CY, et al. MiR-148b suppresses cell proliferation and invasion in hepatocellular carcinoma by targeting WNT1\/\u03b2-catenin pathway. Sci Rep. 2015;5:8087.","journal-title":"Sci Rep"},{"issue":"1","key":"4340_CR14","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/hep.23660","volume":"52","author":"J Huang","year":"2010","unstructured":"Huang J, Wang Y, Guo Y, Sun S. Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1. Hepatology. 2010;52(1):60\u201370.","journal-title":"Hepatology"},{"key":"4340_CR15","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fonc.2015.00068","volume":"5","author":"K Sidhu","year":"2015","unstructured":"Sidhu K, Kapoor NR, Pandey V, Kumar V. The \u201cMacro\u201d World of microRNAs in Hepatocellular Carcinoma. Front Oncol. 2015;5:68.","journal-title":"Front Oncol"},{"issue":"33","key":"4340_CR16","doi-asserted-by":"crossref","first-page":"5439","DOI":"10.3748\/wjg.v19.i33.5439","volume":"19","author":"S Khare","year":"2013","unstructured":"Khare S, Zhang Q, Ibdah JA. Epigenetics of hepatocellular carcinoma: role of microRNA. World J Gastroenterol. 2013;19(33):5439\u201345.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4340_CR17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13045-014-0086-0","volume":"7","author":"WT Wang","year":"2014","unstructured":"Wang WT, Chen YQ. Circulating miRNAs in cancer: from detection to therapy. J Hematol Oncol. 2014;7(1):86.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"4340_CR18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4149\/neo_2013_018","volume":"60","author":"J Qi","year":"2013","unstructured":"Qi J, Wang J, Katayama H, Sen S, Liu SM. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma. 2013;60(2):135\u201342.","journal-title":"Neoplasma"},{"issue":"6","key":"4340_CR19","doi-asserted-by":"crossref","first-page":"e0130677","DOI":"10.1371\/journal.pone.0130677","volume":"10","author":"Q Liao","year":"2015","unstructured":"Liao Q, Han P, Huang Y, Wu Z, Chen Q, Li S, et al. Potential role of circulating microRNA-21 for hepatocellular carcinoma diagnosis: a meta-analysis. PLoS One. 2015;10(6):e0130677.","journal-title":"PLoS One"},{"issue":"6","key":"4340_CR20","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1007\/s13277-015-3092-0","volume":"36","author":"J Yin","year":"2015","unstructured":"Yin J, Hou P, Wu Z, Wang T, Nie Y. Circulating miR-375 and miR-199a-3p as potential biomarkers for the diagnosis of hepatocellular carcinoma. Tumour Biol. 2015;36(6):4501\u20137.","journal-title":"Tumour Biol"},{"issue":"10","key":"4340_CR21","doi-asserted-by":"crossref","first-page":"7439","DOI":"10.1007\/s13277-015-3430-2","volume":"36","author":"L Chen","year":"2015","unstructured":"Chen L, Chu F, Cao Y, Shao J, Wang F. Serum miR-182 and miR-331-3p as diagnostic and prognostic markers in patients with hepatocellular carcinoma. Tumour Biol. 2015;36(10):7439\u201347.","journal-title":"Tumour Biol"},{"issue":"2","key":"4340_CR22","first-page":"630","volume":"123","author":"X Xu","year":"2013","unstructured":"Xu X, Fan Z, Kang L, Han J, Jiang C, Zheng X, et al. Hepatitis B virus X protein represses miRNA-148a to enhance tumorigenesis. J Clin Invest. 2013;123(2):630\u201345.","journal-title":"J Clin Invest"},{"issue":"9","key":"4340_CR23","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.18632\/oncotarget.1920","volume":"5","author":"MJ Heo","year":"2014","unstructured":"Heo MJ, Kim YM, Koo JH, Yang YM, An J, Lee SK, et al. microRNA-148a dysregulation discriminates poor prognosis of hepatocellular carcinoma in association with USP4 overexpression. Oncotarget. 2014;5(9):2792\u2013806.","journal-title":"Oncotarget"},{"issue":"12","key":"4340_CR24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1002\/mc.22064","volume":"53","author":"H Yan","year":"2014","unstructured":"Yan H, Dong X, Zhong X, Ye J, Zhou Y, Yang X, et al. Inhibitions of epithelial to mesenchymal transition and cancer stem cells-like properties are involved in miR-148a-mediated anti-metastasis of hepatocellular carcinoma. Mol Carcinog. 2014;53(12):960\u20139.","journal-title":"Mol Carcinog"},{"issue":"5","key":"4340_CR25","doi-asserted-by":"crossref","first-page":"e96698","DOI":"10.1371\/journal.pone.0096698","volume":"9","author":"F Jiang","year":"2014","unstructured":"Jiang F, Mu J, Wang X, Ye X, Si L, Ning S, et al. The repressive effect of miR-148a on TGF beta-SMADs signal pathway is involved in the glabridin- induced inhibition of the cancer stem cells-like properties in hepatocellular carcinoma cells. PLoS One. 2014;9(5):e96698.","journal-title":"PLoS One"},{"key":"4340_CR26","doi-asserted-by":"crossref","unstructured":"Liu Q, Xu Y, Wei S, Gao W, Chen L, Zhou T, et al. miRNA-148b suppresses hepatic cancer stem cell by targeting neuropilin-1. Biosci Rep. 2015;35(4). doi: 10.1042\/BSR20150084 .","DOI":"10.1042\/BSR20150084"},{"issue":"6","key":"4340_CR27","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1007\/s12032-014-0984-6","volume":"31","author":"Z Zhang","year":"2014","unstructured":"Zhang Z, Zheng W, Hai J. MicroRNA-148b expression is decreased in hepato- cellular carcinoma and associated with prognosis. Med Oncol. 2014;31(6):984.","journal-title":"Med Oncol"},{"issue":"1","key":"4340_CR28","doi-asserted-by":"crossref","first-page":"e81730","DOI":"10.1371\/journal.pone.0081730","volume":"9","author":"S Huang","year":"2014","unstructured":"Huang S, Xie Y, Yang P, Chen P, Zhang L. HCV core protein-induced down-regulation of microRNA-152 promoted aberrant proliferation by regulating Wnt1 in HepG2 cells. PLoS One. 2014;9(1):e81730.","journal-title":"PLoS One"},{"issue":"12","key":"4340_CR29","doi-asserted-by":"crossref","first-page":"4969","DOI":"10.7314\/APJCP.2014.15.12.4969","volume":"15","author":"YW Dang","year":"2014","unstructured":"Dang YW, Zeng J, He RQ, Rong MH, Luo DZ, Chen G. Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. Asian Pac J Cancer Prev. 2014;15(12):4969\u201376.","journal-title":"Asian Pac J Cancer Prev"},{"key":"4340_CR30","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.12659\/MSM.892940","volume":"21","author":"L Li","year":"2015","unstructured":"Li L, Chen YY, Li SQ, Huang C, Qin YZ. Expression of miR-148\/152 family as potential biomarkers in non-small-cell lung cancer. Med Sci Monit. 2015;21:1155\u201361.","journal-title":"Med Sci Monit"},{"issue":"4","key":"4340_CR31","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s13277-014-2938-1","volume":"36","author":"JS Yang","year":"2015","unstructured":"Yang JS, Li BJ, Lu HW, Chen Y, Lu C, Zhu RX, et al. Serum miR-152, miR-148a, miR-148b, and miR-21 as novel biomarkers in non-small cell lung cancer screening. Tumour Biol. 2015;36(4):3035\u201342.","journal-title":"Tumour Biol"},{"key":"4340_CR32","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40001-014-0068-2","volume":"19","author":"L Pan","year":"2014","unstructured":"Pan L, Huang S, He R, Rong M, Dang Y, Chen G. Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues. Eur J Med Res. 2014;19:68.","journal-title":"Eur J Med Res"},{"issue":"5","key":"4340_CR33","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1007\/s12032-012-0303-z","volume":"29","author":"HB Le","year":"2012","unstructured":"Le HB, Zhu WY, Chen DD, He JY, Huang YY, Liu XG, et al. Evaluation of dynamic change of serum miR-21 and miR-24 in pre- and post-operative lung carcinoma patients. Med Oncol. 2012;29(5):3190\u20137.","journal-title":"Med Oncol"},{"issue":"1","key":"4340_CR34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/cncr.28981","volume":"121","author":"NH Fleming","year":"2015","unstructured":"Fleming NH, Zhong J, da Silva IP, Vega-Saenz de Miera E, Brady B, Han SW, et al. Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients. Cancer. 2015;121(1):51\u20139.","journal-title":"Cancer"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4340-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-015-4340-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-015-4340-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T21:02:17Z","timestamp":1599771737000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-015-4340-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,3]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["4340"],"URL":"https:\/\/doi.org\/10.1007\/s13277-015-4340-z","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,3]]}}}